Market Quotes

2235 items in section

EIR Biopharma Files for IPO to Fund Eye Disease Pipeline

EIR Biopharma, an early-stage biotechnology firm specializing in ophthalmology, filed for an initial public offering on Tuesday to advance its lead therapeutic candidate. The company plans to sell 3.75 million shares of common stock at a price range of $4 to $5 per share, according to a filing with the Securities and Exchange Commission.

Plutonian Acquisition II Targets $100 Million in NYSE Listing

Plutonian Acquisition Corp II, a Cayman Islands-based blank-check firm, filed for a $100 million initial public offering on Tuesday to target the energy storage and telecommunications sectors. The company intends to list on the New York Stock Exchange under the ticker PLUNU, marking its entry into the search for a strategic merger partner.

Health Care Stocks Slip as $10 Billion Danaher Deal Meets Mixed Earnings

Health care stocks edged lower on Tuesday as a major $10 billion acquisition by Danaher failed to offset a wave of mixed corporate earnings and concerns over future trade policy. While significant deal activity provided a boost, cautious outlooks from industry leaders and ongoing legal pressures weighed on broader sector performance.

General Mills Profit Warning Triggers Consumer Sector Sell-Off

Consumer staples stocks tumbled after General Mills slashed its full-year outlook, citing a sharp pullback in household spending. The food processing giant’s warning resonated across the sector, dragging down competitors and highlighting the impact of persistent inflation on consumer behavior.

NovaBridge Advances Phase 2 Gastric Cancer Trial for Givastomig

NovaBridge Biosciences has initiated a Phase 2 clinical trial for givastomig, dosing the first patient in a study targeting HER2-negative metastatic gastric cancer. The company expects to report top-line data from the trial, which combines the drug with nivolumab and chemotherapy, by 2027.

EQT Beats Estimates as Winter Storms Drive Natural Gas Revenue

EQT reported a 47% revenue surge in the fourth quarter, capitalizing on increased natural gas demand and price spikes triggered by severe winter weather. The producer delivered adjusted earnings of 90 cents per share, comfortably exceeding Wall Street expectations as operational efficiencies helped the company navigate seasonal volatility.

Amrize Announces $1 Billion Buyback and New Dividend Strategy

Amrize, a major player in the building materials sector, has authorized a $1 billion share repurchase program and a special dividend to return capital to its investors. The initiatives, announced Tuesday, are contingent on shareholder approval of the company's 2025 financial performance at its next annual general meeting.

Republic Services Beats Profit Estimates Despite Revenue Miss

Republic Services reported a fourth-quarter net income of $545 million, exceeding analyst expectations for earnings per share even as total revenue fell slightly short of Wall Street forecasts. The waste management giant benefited from core organic growth in its recycling and waste segments, offsetting a minor dip in its environmental solutions business.

Devon Energy Outperforms Estimates Ahead of $21.5B Coterra Merger

Devon Energy reported a decline in fourth-quarter profit and revenue as the Oklahoma City-based producer prepares to finalize its $21.5 billion all-stock merger with Coterra Energy. Despite the year-over-year slip, the company’s adjusted earnings beat Wall Street expectations, bolstered by record-setting production levels in the Delaware Basin.

Leonardo DRS Joins Pentagon’s $151 Billion SHIELD Defense Program

Leonardo DRS has secured multiple contracts under the Missile Defense Agency’s (MDA) $151 billion SHIELD program, positioning the defense contractor to support critical homeland defense infrastructure. The awards, announced Tuesday, fall under the Scalable Homeland Innovative Enterprise Layered Defense framework, a massive indefinite-delivery/indefinite-quantity vehicle designed to modernize the U.S. response to evolving aerial threats.

Robinhood to Launch NYSE-Listed Fund for Private Market Access

Robinhood is set to debut its first private-markets fund on the New York Stock Exchange in the coming weeks, offering retail investors a direct path to high-growth startups. The Robinhood Ventures Fund I, trading as RVI, aims to break down the barriers that typically restrict late-stage private investments to institutional players and the ultra-wealthy.

FDA Approves Shield Therapeutics’ AccruFeR for Pediatric Use

The U.S. Food and Drug Administration has authorized Shield Therapeutics to market its oral iron treatment, AccruFeR, for children aged 10 and older. The decision, announced Tuesday, significantly expands the patient base for the London-based biopharmaceutical firm following the drug's initial adult clearance in 2019.

Robinhood to List Private-Market Fund on NYSE for Retail Investors

Robinhood is set to launch its first venture fund on the New York Stock Exchange in the coming weeks, offering retail investors a rare gateway into high-growth private companies. Trading under the ticker RVI, the Robinhood Ventures Fund I aims to dismantle the barriers that have historically kept individual traders out of the private equity space.

VisionWave Shares Surge on $10 Million Crypto Mining Deal

VisionWave shares rose Tuesday after the defense technology firm secured a $10 million agreement to develop a high-performance cryptocurrency mining platform. The deal, structured as a milestone-based program with an undisclosed third-party vendor, marks a strategic expansion for the company into digital asset infrastructure.

Wolfspeed Shares Surge on Appointment of New EMEA Sales Chief

Wolfspeed shares climbed 11% on Tuesday following the appointment of Stefan Steyerl as Vice President of Sales for the EMEA region. The veteran executive, who officially joins the silicon carbide specialist on March 1, is tasked with scaling the company’s market presence across Europe, the Middle East, and Africa as it pivots toward high-growth power electronics.

Harmony Biosciences Wins FDA Nod for Pediatric Cataplexy Drug

The U.S. Food and Drug Administration has approved Harmony Biosciences’ supplemental drug application for Wakix, expanding its use to treat cataplexy in pediatric patients aged six and older. The decision establishes the medication as the first non-scheduled treatment option available for both adults and children suffering from the sudden muscle weakness associated with narcolepsy.

Donnelley Financial Shares Surge on Q4 Revenue Rebound

Donnelley Financial Solutions (DFIN) saw its shares climb 12% on Tuesday after the regulatory software provider snapped a multi-quarter losing streak with fourth-quarter revenue and earnings that significantly outpaced Wall Street estimates.

Oil Prices Retreat as U.S.-Iran Nuclear Talks Signal Progress

Crude oil and refined product futures slid on Tuesday following reports that high-level negotiations between the U.S. and Iran have established a framework for a potential nuclear deal. The prospect of easing geopolitical tensions in the Middle East, combined with looming production decisions from OPEC+, weighed on benchmarks during midday trading.

Microsoft and Ericsson Automate 5G Connectivity for Windows 11

Ericsson and Microsoft announced a partnership on Tuesday to integrate AI-driven 5G capabilities into Windows 11, streamlining how enterprise laptops connect to cellular networks. By merging Microsoft’s device management tools with Ericsson’s Enterprise 5G Connect platform, the collaboration aims to automate network switching and optimize connectivity for corporate fleets.

JFB Construction Shares Plunge 49% on $1.5B Xtend Drone Merger

JFB Construction shares cratered Tuesday after the Florida-based firm announced a $1.5 billion all-stock merger with Israeli drone manufacturer Xtend. The deal, expected to close by mid-2026, will pivot the construction company toward the defense sector under the new name Xtend AI Robotics.

Canaccord Genuity Shares Surge on Record Mining Activity

Canaccord Genuity Group Inc. shares climbed Tuesday after the financial services firm reported third-quarter earnings and revenue that significantly outpaced analyst expectations. Driven by a resurgence in Australian metals and mining activity and record-high gold prices, the company’s profit more than doubled year-over-year, signaling a robust recovery in global capital markets.